EDP-323
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for EDP-323, covering 2025-07-01 to 2025-10-07. Get the full timeline:
Most recent: Clinical Trial Update: A Controlled Phase 2a Study to Evaluate the Efficacy of EDP-323 Against Respiratory Syncytial Virus Infection in a Virus Challenge Model [Phase 2]